New Releases from NCBI BookshelfBiomarker-based tests for deciding for or against adjuvant systemic chemotherapy in primary breast cancer with involvement of 1 to 3 lymph nodes and in premenopausal patients without lymph node involvement: IQWiG Reports – Commission No. D23-01 [Internet].​Biomarker-based tests for deciding for or against adjuvant systemic chemotherapy in primary breast cancer with involvement of 1 to 3 lymph nodes and in premenopausal patients without lymph node involvement: IQWiG Reports – Commission No. D23-01 [Internet].